BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22816192)

  • 1. A critique of race-based and genomic medicine.
    Meier RJ
    Coll Antropol; 2012 Mar; 36(1):5-10. PubMed ID: 22816192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics research involving racial classification: qualitative research findings on researchers' views, perceptions and attitudes towards socioethical responsibilities.
    Egalité N; Ozdemir V; Godard B
    Pharmacogenomics; 2007 Sep; 8(9):1115-26. PubMed ID: 17924827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human genome project: pharmacogenomics and drug development.
    Ganguly NK; Bano R; Seth SD
    Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of personalized medicine in the disease genomic era.
    Hong KW; Oh B
    BMB Rep; 2010 Oct; 43(10):643-8. PubMed ID: 21034525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalizing dermatology: the future of genomic expression profiling to individualize dermatologic therapy.
    Rizzo AE; Maibach HI
    J Dermatolog Treat; 2012 Jun; 23(3):161-7. PubMed ID: 21254882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-tailored medicine, Part one: the impact of race and genetics on medicine.
    Braff JP; Chatterjee B; Hochman M; Kelton T; Kennington J; Kolavala C; Layman K; Parver C; Selby MC; Washlick JR; Wolf R
    J Health Life Sci Law; 2008 Oct; 2(1):1-3, 5-36. PubMed ID: 19004296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacogenetics: towards personalized medicine].
    Gurwitz D; Rehavi M
    Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics and the challenge of health disparities.
    Lee SS
    Public Health Genomics; 2009; 12(3):170-9. PubMed ID: 19204420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will personalized medicine challenge or reify categories of race and ethnicity?
    Rajagopalan R; Fujimura JH
    Virtual Mentor; 2012 Aug; 14(8):657-63. PubMed ID: 23351323
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomics and personalized medicine.
    Sadee W
    Int J Pharm; 2011 Aug; 415(1-2):2-4. PubMed ID: 21539903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine research.
    Kennedy MA; Joyce PR; Begg EJ
    Pharmacogenomics; 2012 Jun; 13(8):865-8. PubMed ID: 22676191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ethical implications of stratifying by race in pharmacogenomics.
    Lee SS
    Clin Pharmacol Ther; 2007 Jan; 81(1):122-5. PubMed ID: 17186010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical practice on the horizon: personalized medicine.
    Chadwell K
    Clin Nurse Spec; 2013; 27(1):36-43. PubMed ID: 23222027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human genome project: opportunities, challenges and consequences for population screening.
    Christodoulou J
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():234-8. PubMed ID: 15906744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual genomes instead of race for personalized medicine.
    Ng PC; Zhao Q; Levy S; Strausberg RL; Venter JC
    Clin Pharmacol Ther; 2008 Sep; 84(3):306-9. PubMed ID: 18714319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.